Remove Medicine Remove Pharmaceutical research Remove Prescription
article thumbnail

The Dark Side of the Pharmaceutical Industry: Are Treatments Being Blocked for Profit?

Pharma Marketing Network

Pharmaceutical research and development: what do we get for all that money? Industry-sponsored clinical research: a broken system. Powerful medicines: the benefits, risks, and costs of prescription drugs. W., & Lexchin, J. British medical journal, 344, e4348. Fugh-Berman, A.

article thumbnail

And so pharma profiteers again

World of DTC Marketing

BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money.

Pharma 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Beating the Big C

Pharmaceutical Technology

” While Pfizer is currently testing 18 medicines targeted against pancreatic, breast and lung cancers, figures released by the Pharmaceutical Research and Manufacturers of America [PhRMA] in April 2008 reveal that research companies are currently testing a record-breaking 750 experimental cancer drugs in America alone. .”

article thumbnail

US Democrats’ blockbuster budget bill could spell big changes for drug prices

pharmaphorum

In addition to the climate provisions, however, the bill has a significant effect on prescription drug prices, and according to reports neither Manchin nor Sinema is objecting to these provisions, which are similar but not identical to the ones in the Build Back Better plan which previously passed in the House of Representatives.